SHIRE HUMAN GENETIC THERAPIES, INC. – Trademark Portfolio
Entity Type: 03
SHIRE HUMAN GENETIC THERAPIES, INC. owns a portfolio of 75 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as VPRIV, BEBRYSA, ONEPATH, COZIPREM, and ELAPRASE. Of these, 14 are registered. The portfolio spans 8 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 42 (Computer & Scientific). Headquartered in CAMBRIDGE, MA.
700 MAIN STREET
CAMBRIDGE, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
SHIRE HUMAN GENETIC THERAPIES, INC.'s trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does SHIRE HUMAN GENETIC THERAPIES, INC. have?
SHIRE HUMAN GENETIC THERAPIES, INC. has 75 U.S. trademarks filed with the USPTO. Of these, 14 registered, 33 abandoned, 28 cancelled.
What trademark classes does SHIRE HUMAN GENETIC THERAPIES, INC. file in?
SHIRE HUMAN GENETIC THERAPIES, INC. files trademarks across 8 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SHIRE HUMAN GENETIC THERAPIES, INC.'s most well-known trademarks?
SHIRE HUMAN GENETIC THERAPIES, INC.'s registered trademark portfolio includes well-known marks such as VPRIV, BEBRYSA, ONEPATH, COZIPREM, and ELAPRASE. These are among 14 currently registered trademarks in the portfolio.
What is SHIRE HUMAN GENETIC THERAPIES, INC.'s trademark registration success rate?
SHIRE HUMAN GENETIC THERAPIES, INC. has a 19% trademark registration rate, with 14 out of 75 resolved applications resulting in successful registration. Currently, 0 applications are pending review.